Cheap cholesterol pill may shield diabetic kidneys
NCT ID NCT04929379
Summary
This study is testing if fenofibrate, an inexpensive generic drug used to lower blood fats, can help prevent kidney damage in people with type 1 diabetes. It will enroll 40 adults with type 1 diabetes and early-to-moderate kidney disease to take either fenofibrate or a placebo for 18 months. The main goal is to see if the drug can slow the loss of kidney function and gather information to plan a larger future trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brehm Center for Diabetes Research / University of Michigan
Ann Arbor, Michigan, 48105, United States
-
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
-
Lahey Hospital and Medical center
Burlington, Massachusetts, 01805, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13210, United States
Conditions
Explore the condition pages connected to this study.